Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
183 participants
INTERVENTIONAL
2012-11-30
2019-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acupuncture/Moxibustion for Irritable Bowel Syndrome (IBS)
NCT00945074
Acupuncture for Irritable Bowel Syndrome (IBS)
NCT00093327
Acupuncture for Irritable Bowel Syndrome
NCT00065403
Effect of Acupuncture on Symptoms of Diarrhea and Pain in IBS
NCT00219505
Moxibustion for Diarrhea-predominant Irritable Bowel Syndrome
NCT02421627
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard
Fixed protocol
Standard protocol
Subjects will receive a standard treatment
Individualized
Individualized protocol
Individualized protocol
Subjects will receive an individualized treatment
Control
Sham acupuncture/Placebo moxa
Sham acupuncture/Placebo moxa
Subjects will receive sham acupuncture/placebo moxa
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard protocol
Subjects will receive a standard treatment
Individualized protocol
Subjects will receive an individualized treatment
Sham acupuncture/Placebo moxa
Subjects will receive sham acupuncture/placebo moxa
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of IBS based on ROME III criteria.
* Complete symptom diaries and return completed diaries at all sessions.
Exclusion Criteria
* Alarm symptoms according to ROME III.
* Individuals currently receiving other types of complementary therapies.
* Individuals with an acute medical condition requiring acute medical attention.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Nursing Research (NINR)
NIH
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Joyce K Anastasi, PhD
Role: PRINCIPAL_INVESTIGATOR
New York University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
NYU Division of Special Studies in Symptom Management
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
12-02325
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.